DUX4 and Facioscapulohumeral dystrophy: Currently, no disease-modifying treatments exist for FSHD.5 With emerging potential DUX4-targeting therapies11 and ongoing adult trials, understanding childhood FSHD's natural history and identifying sensitive end points are crucial.